{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "FRA", "shortName": "RECCE PHARMACEUTICALS LTD", "longName": "Recce Pharmaceuticals Ltd", "messageBoardId": "finmb_310479285", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChangePercent": 4.347827, "regularMarketPrice": 0.384, "marketState": "REGULAR", "sharesOutstanding": 178254000, "bookValue": 0.007, "fiftyDayAverage": 0.36444, "fiftyDayAverageChange": 0.01956001, "fiftyDayAverageChangePercent": 0.053671412, "twoHundredDayAverage": 0.43289, "twoHundredDayAverageChange": -0.048889995, "twoHundredDayAverageChangePercent": -0.11293861, "marketCap": 72986496, "priceToBook": 54.857143, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1589781600000, "priceHint": 4, "regularMarketChange": 0.016000003, "regularMarketTime": 1683892036, "regularMarketDayHigh": 0.384, "regularMarketDayRange": "0.384 - 0.384", "regularMarketDayLow": 0.384, "regularMarketVolume": 2950, "regularMarketPreviousClose": 0.368, "bid": 0.0, "ask": 0.0, "fullExchangeName": "Frankfurt", "financialCurrency": "AUD", "regularMarketOpen": 0.384, "averageDailyVolume3Month": 66, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.055999994, "fiftyTwoWeekLowChangePercent": 0.17073168, "fiftyTwoWeekRange": "0.328 - 0.63", "fiftyTwoWeekHighChange": -0.24599999, "fiftyTwoWeekHighChangePercent": -0.39047617, "fiftyTwoWeekLow": 0.328, "fiftyTwoWeekHigh": 0.63, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.05, "symbol": "R9Q.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Aurora Place", "address2": "Level 25 88 Phillip Street", "city": "Sydney", "state": "NSW", "zip": "2000", "country": "Australia", "phone": "61 2 9256 2571", "website": "https://www.recce.com.au", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Recce Pharmaceuticals Ltd, a biotechnology company, engages in the research, development, and commercialization of synthetic anti\u0096infectives in Australia, the United States, and the United Kingdom. The company's lead candidate is RECCE 327 to treat blood infections and sepsis derived from E. coli and S. aureus bacteria, including their superbug forms. It also develops RECCE 529, a synthetic anti-infective for viral infections; and RECCE 435, a synthetic polymer anti-infective. The company was formerly known as Recce Limited and changed its name to Recce Pharmaceuticals Ltd in November 2017. Recce Pharmaceuticals Ltd was incorporated in 2007 and is headquartered in Sydney, Australia.", "companyOfficers": [{"maxAge": 1, "name": "Mr. James Hamilton-Bray Graham GAICD", "title": "CEO, MD & Exec. Director", "fiscalYear": 2022, "totalPay": {"raw": 371746, "fmt": "371.75k", "longFmt": "371,746"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Michele Keryn Dilizia BA (Journ), BSc (Med Sci)", "title": "Chief Scientific Director & Exec. Director", "fiscalYear": 2022, "totalPay": {"raw": 250186, "fmt": "250.19k", "longFmt": "250,186"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Justin  Ward", "title": "Principal Quality Chemist & Exec. Director", "fiscalYear": 2022, "totalPay": {"raw": 141029, "fmt": "141.03k", "longFmt": "141,029"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Arthur  Kollaras", "title": "Principal Engineer & Head of Manufacturing", "fiscalYear": 2022, "totalPay": {"raw": 122646, "fmt": "122.65k", "longFmt": "122,646"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Justin  Reynolds", "title": "Chief Financial Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Thomas  Jarrett", "title": "Operations Mang.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Daniel  Astudillo B.A., B.Com., M.B.A.", "title": "Head of Marketing", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Maggie  Niewidok", "title": "Company Sec.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}